Waters Announces Launch Of Reserve-Phased Drug Production Platform To Separate Impurities In GLP-1 Peptides, Insulin, And Lipid Nanoparticles

뉴스 본문을 불러오고 있어요.

Waters Announces Launch Of Reserve-Phased Drug Production Platform To Separate Impurities In GLP-1 Peptides, Insulin, And Lipid Nanoparticles | 웨이프 WAPE

Waters Announces Launch Of Reserve-Phased Drug Production Platform To Separate Impurities In GLP-1 Peptides, Insulin, And Lipid Nanoparticles

기사 요약

관련 종목

댓글 —